GRAIL to Present Final Multi-cancer Early Detection Data From the Interventional PATHFINDER Study at ESMO Congress 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NHS-Galleri Trial Evaluates Clinical Utility of GRAIL's Galleri Multi-Cancer Early Detection Test Alongside Current Standard of Care to Reduce Later-Stage Cancer Diagnoses Study Prioritizes Equitable
/PRNewswire/ Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference at 1:00 p.m. ET on Thursday, Jan. 6,.